Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era

Jennifer M. Lobo, George J. Stukenborg, Daniel Trifiletti, Nirav Patel, Timothy N. Showalter

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: We developed a decision analysis framework to simulate the clinical choice of early adjuvant versus delayed salvage radiation therapy after radical prostatectomy. Materials & methods: We designed a Markov decision analysis model to represent two alternative treatment approaches for prostate cancer after prostatectomy over a 10-year time horizon. The model contained individualized inputs including genomic classifier score. Sensitivity analyses were performed to evaluate model results. Results: Observation with delayed salvage radiation is preferred according to the base case, with greater average length and quality of life. However, adjuvant therapy is preferred over observation with salvage when genomics-based estimates of recurrence are high. Conclusion: Model results were sensitive to genomics-based estimates of cancer recurrence and to nonprostate cancer mortality.

Original languageEnglish (US)
Pages (from-to)375-382
Number of pages8
JournalJournal of Comparative Effectiveness Research
Volume5
Issue number4
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Salvage Therapy
Decision Support Techniques
Prostatectomy
Genomics
Prostatic Neoplasms
Radiotherapy
Observation
Recurrence
Neoplasms
Quality of Life
Radiation
Mortality
Therapeutics

Keywords

  • comparative effectiveness research
  • genomics
  • oncology

ASJC Scopus subject areas

  • Health Policy

Cite this

Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era. / Lobo, Jennifer M.; Stukenborg, George J.; Trifiletti, Daniel; Patel, Nirav; Showalter, Timothy N.

In: Journal of Comparative Effectiveness Research, Vol. 5, No. 4, 01.07.2016, p. 375-382.

Research output: Contribution to journalArticle

Lobo, Jennifer M. ; Stukenborg, George J. ; Trifiletti, Daniel ; Patel, Nirav ; Showalter, Timothy N. / Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era. In: Journal of Comparative Effectiveness Research. 2016 ; Vol. 5, No. 4. pp. 375-382.
@article{b3ff326e56cb4078882d14503c5bcd8d,
title = "Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era",
abstract = "Aim: We developed a decision analysis framework to simulate the clinical choice of early adjuvant versus delayed salvage radiation therapy after radical prostatectomy. Materials & methods: We designed a Markov decision analysis model to represent two alternative treatment approaches for prostate cancer after prostatectomy over a 10-year time horizon. The model contained individualized inputs including genomic classifier score. Sensitivity analyses were performed to evaluate model results. Results: Observation with delayed salvage radiation is preferred according to the base case, with greater average length and quality of life. However, adjuvant therapy is preferred over observation with salvage when genomics-based estimates of recurrence are high. Conclusion: Model results were sensitive to genomics-based estimates of cancer recurrence and to nonprostate cancer mortality.",
keywords = "comparative effectiveness research, genomics, oncology",
author = "Lobo, {Jennifer M.} and Stukenborg, {George J.} and Daniel Trifiletti and Nirav Patel and Showalter, {Timothy N.}",
year = "2016",
month = "7",
day = "1",
doi = "10.2217/cer-2015-0015",
language = "English (US)",
volume = "5",
pages = "375--382",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era

AU - Lobo, Jennifer M.

AU - Stukenborg, George J.

AU - Trifiletti, Daniel

AU - Patel, Nirav

AU - Showalter, Timothy N.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Aim: We developed a decision analysis framework to simulate the clinical choice of early adjuvant versus delayed salvage radiation therapy after radical prostatectomy. Materials & methods: We designed a Markov decision analysis model to represent two alternative treatment approaches for prostate cancer after prostatectomy over a 10-year time horizon. The model contained individualized inputs including genomic classifier score. Sensitivity analyses were performed to evaluate model results. Results: Observation with delayed salvage radiation is preferred according to the base case, with greater average length and quality of life. However, adjuvant therapy is preferred over observation with salvage when genomics-based estimates of recurrence are high. Conclusion: Model results were sensitive to genomics-based estimates of cancer recurrence and to nonprostate cancer mortality.

AB - Aim: We developed a decision analysis framework to simulate the clinical choice of early adjuvant versus delayed salvage radiation therapy after radical prostatectomy. Materials & methods: We designed a Markov decision analysis model to represent two alternative treatment approaches for prostate cancer after prostatectomy over a 10-year time horizon. The model contained individualized inputs including genomic classifier score. Sensitivity analyses were performed to evaluate model results. Results: Observation with delayed salvage radiation is preferred according to the base case, with greater average length and quality of life. However, adjuvant therapy is preferred over observation with salvage when genomics-based estimates of recurrence are high. Conclusion: Model results were sensitive to genomics-based estimates of cancer recurrence and to nonprostate cancer mortality.

KW - comparative effectiveness research

KW - genomics

KW - oncology

UR - http://www.scopus.com/inward/record.url?scp=84978140907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978140907&partnerID=8YFLogxK

U2 - 10.2217/cer-2015-0015

DO - 10.2217/cer-2015-0015

M3 - Article

C2 - 27294829

AN - SCOPUS:84978140907

VL - 5

SP - 375

EP - 382

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 4

ER -